Fortress Biotech Inc (FBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 34,752 | 17,386 | 12,429 | 16,404 | 16,528 |
| Cost of Goods | 6,429 | 7,767 | 6,449 | 7,718 | 7,221 |
| Gross Profit | 28,323 | 9,619 | 5,980 | 8,686 | 9,307 |
| Operating Expenses | 42,510 | 60,491 | 65,296 | 64,038 | 60,262 |
| Operating Income | -13,758 | -50,105 | -58,867 | -54,634 | -50,734 |
| Interest Expense | 2,534 | 6,425 | 4,296 | 4,745 | 3,393 |
| Other Income | 5,709 | -2,771 | 8,018 | 2,383 | 1,067 |
| Pre-tax Income | -10,583 | -59,301 | -55,145 | -56,996 | -53,060 |
| Income Tax | 141 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -10,724 | -59,301 | -55,145 | -57,445 | -53,060 |
| Minority Interests | -5,679 | -34,525 | -33,608 | -30,497 | -30,549 |
| Net Income | $-5,045 | $-24,776 | $-21,537 | $-26,948 | $-22,511 |
| EPS Basic Total Ops | -0.94 | -3.65 | -3.47 | -5.26 | -4.11 |
| EPS Basic Continuous Ops | -1.43 | -8.04 | -8.12 | -9.49 | -8.90 |
| EPS Diluted Total Ops | -0.94 | -3.65 | -3.47 | -5.26 | -4.11 |
| EPS Diluted Continuous Ops | -1.43 | -8.04 | -8.12 | -9.49 | -8.90 |
| EBITDA(a) | $-11,401 | $-46,653 | $-55,786 | $-51,477 | $-47,837 |